Archives for March 17, 2008

← 2008

Sartorius mergers cap off 'a successful and intense 2007'

By  Wai Lang Chu

A successful and strategically important year,' is how Sartorius CEO Joachim Kreuzburg described 2007, a year highlighted by merger of its biotechnology division with Stedim to boost its presence in the burgeoning biopharmaceutical market.

GMP an unnecessary burden for excipients, review concludes

By  Pete Mansell

The costs of introducing any formal good manufacturing practice (GMP) requirements for potentially high-risk pharmaceutical excipients in the European Union would far exceed the likely benefits, concludes an impact assessment for the European Commission.